Cerro Pacific Wealth Advisors LLC Novartis Ag Transaction History

Cerro Pacific Wealth Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$80.52 - $93.75 $36,797 - $42,843	-457 Reduced 14.52%	2,691 $227,000
Q1 2022 Apr 13, 2022	SELL	$80.11 - $90.62 $5,287 - $5,980	-66 Reduced 2.05%	3,148 $276,000
Q4 2021 Jan 19, 2022	SELL	$79.7 - $88.13 $61,528 - $68,036	-772 Reduced 19.37%	3,214 $281,000
Q3 2021 Nov 09, 2021	SELL	$81.78 - $95.14 $117,599 - $136,811	-1,438 Reduced 26.51%	3,986 $326,000
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $296,890 - $327,924	-3,483 Reduced 39.1%	5,424 $495,000
Q4 2020 Feb 12, 2021	BUY	$78.07 - $94.43 $695,369 - $841,088	8,907 New	8,907 $841,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $226B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Cerro Pacific Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cerro Pacific Wealth Advisors LLC with notifications on news.